Patents by Inventor Robert I. Connelly
Robert I. Connelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9937290Abstract: A wearable, self-contained drug infusion device is disclosed that is capable of achieving the precise flow rate control needed for dose-critical drugs such as insulin. In preferred embodiments of the device, at least two flow channels are utilized in conjunction with a series of valves for providing a user with selectable, constant flow rate control. The device can be made with small dimensions so that it can be worn by the user with a minimum of discomfort and inconvenience. In addition, the simple mechanical nature of the device provides the user with close control over the flow rate, which is required for safe and effective delivery of insulin and other drugs. Also, the absence of electronic components allows the device to be manufactured inexpensively. The device is provided with a first channel that is long and narrow, functioning as a flow restrictor. The first channel is preferably provided in a serpentine pattern.Type: GrantFiled: July 7, 2014Date of Patent: April 10, 2018Assignee: Becton, Dickinson and CompanyInventors: Robert I. Connelly, Kenneth G. Powell
-
Publication number: 20150011937Abstract: A wearable, self-contained drug infusion device is disclosed that is capable of achieving the precise flow rate control needed for dose-critical drugs such as insulin. In preferred embodiments of the device, at least two flow channels are utilized in conjunction with a series of valves for providing a user with selectable, constant flow rate control. The device can be made with small dimensions so that it can be worn by the user with a minimum of discomfort and inconvenience. In addition, the simple mechanical nature of the device provides the user with close control over the flow rate, which is required for safe and effective delivery of insulin and other drugs. Also, the absence of electronic components allows the device to be manufactured inexpensively. The device is provided with a first channel that is long and narrow, functioning as a flow restrictor. The first channel is preferably provided in a serpentine pattern.Type: ApplicationFiled: July 7, 2014Publication date: January 8, 2015Applicant: BECTON, DICKINSON AND COMPANYInventors: Robert I. Connelly, Kenneth G. Powell
-
Patent number: 8771227Abstract: A wearable, self-contained drug infusion device is disclosed that is capable of achieving the precise flow rate control needed for dose-critical drugs such as insulin. In preferred embodiments of the device, at least two flow channels are utilized in conjunction with a series of valves for providing a user with selectable, constant flow rate control. The device can be made with small dimensions so that it can be worn by the user with a minimum of discomfort and inconvenience. In addition, the simple mechanical nature of the device provides the user with close control over the flow rate, which is required for safe and effective delivery of insulin and other drugs. Also, the absence of electronic components allows the device to be manufactured inexpensively. The device is provided with a first channel that is long and narrow, functioning as a flow restrictor. The first channel is preferably provided in a serpentine pattern.Type: GrantFiled: February 13, 2004Date of Patent: July 8, 2014Assignee: Becton, Dickinson and CompanyInventors: Robert I. Connelly, Kenneth G. Powell
-
Patent number: 8459257Abstract: A medicament delivery device for administering a medicament to a user includes a medicament reservoir and an entrance port and an exit port each disposed adjacent the reservoir. A gas chamber disposed adjacent the entrance port. The device includes a pressurizing mechanism operable to pressurize said gas chamber to at least a prescribed pressure. A first frangible membrane extends across the entrance port and separates the reservoir from the gas chamber. A second frangible membrane extends across the exit port. When the pressurizing mechanism is attached, at least one of the first and second membranes is responsive to the prescribed pressure in the gas chamber to burst to allow gas to flow through the entrance port and the reservoir and to carry the medicament through the exit port.Type: GrantFiled: May 22, 2009Date of Patent: June 11, 2013Assignee: Becton, Dickinson and CompanyInventors: Robert I. Connelly, Vincent J. Sullivan, Charles D. Shermer, Anjana Bhuta, Ronald J. Pettis
-
Publication number: 20090223516Abstract: A medicament delivery device for administering a medicament to a user includes a medicament reservoir and an entrance port and an exit port each disposed adjacent the reservoir. A gas chamber disposed adjacent the entrance port. The device includes a pressurizing mechanism operable to pressurize said gas chamber to at least a prescribed pressure. A first frangible membrane extends across the entrance port and separates the reservoir from the gas chamber. A second frangible membrane extends across the exit port. When the pressurizing mechanism is attached, at least one of the first and second membranes is responsive to the prescribed pressure in the gas chamber to burst to allow gas to flow through the entrance port and the reservoir and to carry the medicament through the exit port.Type: ApplicationFiled: May 22, 2009Publication date: September 10, 2009Inventors: Robert I. Connelly, Vincent J. Sullivan, Charles D. Shermer, Anjana Bhuta, Ronald J. Pettis
-
Patent number: 7540285Abstract: A medicament delivery device for administering a medicament to a user includes a medicament reservoir and an entrance port and an exit port and a gas chamber disposed adjacent the entrance port. The device includes a pressurizing mechanism to pressurize the gas chamber. The device also contains frangible membranes and may include a piercing member. In use, the frangible membranes in the device are responsive to pressure in the gas chamber and are either pierced or burst to allow gas to flow through the entrance port and the reservoir and to carry the medicament through the exit port.Type: GrantFiled: March 7, 2006Date of Patent: June 2, 2009Assignee: Becton, Dickinson and CompanyInventors: Robert I. Connelly, Vincent J. Sullivan, Charles D. Shermer, Anjana Bhuta, Ronald J. Pettis
-
Patent number: 7040316Abstract: A medicament delivery device for administering a medicament to a user includes a medicament reservoir and an entrance port and an exit port each disposed adjacent the reservoir. A gas chamber disposed adjacent the entrance port. The device includes a pressurizing mechanism operable to pressurize said gas chamber to at least a prescribed pressure. A first frangible membrane extends across the entrance port and separates the reservoir from the gas chamber. A second frangible membrane extends across the exit port. When the pressurizing mechanism is attached, at least one of the first and second membranes is responsive to the prescribed pressure in the gas chamber to burst to allow gas to flow through the entrance port and the reservoir and to carry the medicament through the exit port.Type: GrantFiled: March 3, 2004Date of Patent: May 9, 2006Assignee: Becton, Dickinson and CompanyInventors: Robert I. Connelly, Vincent J. Sullivan, Charles D. Shermer, Anjana Bhuta, Ronald J. Pettis
-
Publication number: 20040163645Abstract: A medicament delivery device for administering a medicament to a user includes a medicament reservoir and an entrance port and an exit port each disposed adjacent the reservoir. A gas chamber disposed adjacent the entrance port. The device includes a pressurizing mechanism operable to pressurize said gas chamber to at least a prescribed pressure. A first frangible membrane extends across the entrance port and separates the reservoir from the gas chamber. A second frangible membrane extends across the exit port. When the pressurizing mechanism is attached, at least one of the first and second membranes is responsive to the prescribed pressure in the gas chamber to burst to allow gas to flow through the entrance port and the reservoir and to carry the medicament through the exit port.Type: ApplicationFiled: March 3, 2004Publication date: August 26, 2004Inventors: Robert I. Connelly, Vincent J. Sullivan, Charles D. Shermer, Anjana Bhuta, Ronald J. Pettis
-
Publication number: 20040162518Abstract: A wearable, self-contained drug infusion device is disclosed that is capable of achieving the precise flow rate control needed for dose-critical drugs such as insulin. In preferred embodiments of the device, at least two flow channels are utilized in conjunction with a series of valves for providing a user with selectable, constant flow rate control. The device can be made with small dimensions so that it can be worn by the user with a minimum of discomfort and inconvenience. In addition, the simple mechanical nature of the device provides the user with close control over the flow rate, which is required for safe and effective delivery of insulin and other drugs. Also, the absence of electronic components allows the device to be manufactured inexpensively. The device is provided with a first channel that is long and narrow, functioning as a flow restrictor. The first channel is preferably provided in a serpentine pattern.Type: ApplicationFiled: February 13, 2004Publication date: August 19, 2004Inventors: Robert I. Connelly, Kenneth G. Powell
-
Patent number: 6722364Abstract: A medicament delivery device for administering a medicament to a user includes a medicament reservoir and an entrance port and an exit port each disposed adjacent the reservoir. A gas chamber disposed adjacent the entrance port. The device includes a pressurizing mechanism operable to pressurize said gas chamber to at least a prescribed pressure. A first frangible membrane extends across the entrance port and separates the reservoir from the gas chamber. A second frangible membrane extends across the exit port. When the pressurizing mechanism is attached, at least one of the first and second membranes is responsive to the prescribed pressure in the gas chamber to burst to allow gas to flow through the entrance port and the reservoir and to carry the medicament through the exit port.Type: GrantFiled: January 12, 2001Date of Patent: April 20, 2004Assignee: Becton, Dickinson and CompanyInventors: Robert I. Connelly, Vincent J. Sullivan, Charles D. Shermer, Anjana Bhuta, Ronald J. Pettis
-
Patent number: 6702779Abstract: A wearable, self-contained drug infusion device is disclosed that is capable of achieving the precise flow rate control needed for dose-critical drugs such as insulin. In preferred embodiments of the device, at least two flow channels are utilized in conjunction with a series of valves for providing a user with selectable, constant flow rate control. The device can be made with small dimensions so that it can be worn by the user with a minimum of discomfort and inconvenience. In addition, the simple mechanical nature of the device provides the user with close control over the flow rate, which is required for safe and effective delivery of insulin and other drugs. Also, the absence of electronic components allows the device to be manufactured inexpensively. The device is provided with a first channel that is long and narrow, functioning as a flow restrictor. The first channel is preferably provided in a serpentine pattern.Type: GrantFiled: August 17, 2001Date of Patent: March 9, 2004Assignee: Becton, Dickinson and CompanyInventors: Robert I. Connelly, Kenneth G. Powell
-
Patent number: 6689100Abstract: A device for withdrawing or delivering a substance through the skin of a patient includes a body and a skin penetrating device having a plurality of skin penetrating members, such microneedles. The body includes a bottom surface having a first inner surface area supporting the skin penetrating members and a second outer surface having an adhesive for attaching the device to the skin. In one embodiment, the firs inner surface is spaced outwardly from the second outer surface when the device is attached to the skin. The inner surface can have a textured visually wettable surface, such as an etched surface, to provide a visual indication of leakage from the interface between the skin penetrating members and the skin.Type: GrantFiled: October 5, 2001Date of Patent: February 10, 2004Assignee: Becton, Dickinson and CompanyInventors: Robert I. Connelly, Ronald J. Pettis
-
Patent number: 6589229Abstract: A wearable, self contained drug infusion device is disclosed that is capable of achieving the precise flow rate control needed for dose-critical drugs such as insulin. In preferred embodiments of the device, piezoelectrically-actuated valve or pump structures are used in combination with thermal flow sensors and closed-loop control circuits for providing the desired flow rate control. The device has a two-part construction in which the more expensive electronic components are housed in a reusable portion and the fluid delivery components are housed in a separable disposable portion. The invention may also utilize a wireless unit for controlling the operation of the drug infusion device.Type: GrantFiled: July 31, 2000Date of Patent: July 8, 2003Assignee: Becton, Dickinson and CompanyInventors: Robert I. Connelly, Charles D. Shermer, Kenneth G. Powell
-
Publication number: 20030069548Abstract: A device for withdrawing or delivering a substance through the skin of a patient includes a body and a skin penetrating device having a plurality of skin penetrating members, such microneedles. The body includes a bottom surface having a first inner surface area supporting the skin penetrating members and a second outer surface having an adhesive for attaching the device to the skin. In one embodiment, the firs inner surface is spaced outwardly from the second outer surface when the device is attached to the skin. The inner surface can have a textured visually wettable surface, such as an etched surface, to provide a visual indication of leakage from the interface between the skin penetrating members and the skin.Type: ApplicationFiled: October 5, 2001Publication date: April 10, 2003Inventors: Robert I. Connelly, Ronald J. Pettis
-
Publication number: 20020092523Abstract: A medicament delivery device for administering a medicament to a user includes a medicament reservoir and an entrance port and an exit port each disposed adjacent the reservoir. A gas chamber disposed adjacent the entrance port. The device includes a pressurizing mechanism operable to pressurize said gas chamber to at least a prescribed pressure. A first frangible membrane extends across the entrance port and separates the reservoir from the gas chamber. A second frangible membrane extends across the exit port. When the pressurizing mechanism is attached, at least one of the first and second membranes is responsive to the prescribed pressure in the gas chamber to burst to allow gas to flow through the entrance port and the reservoir and to carry the medicament through the exit port.Type: ApplicationFiled: January 12, 2001Publication date: July 18, 2002Inventors: Robert I. Connelly, Vincent J. Sullivan, Charles D. Shermer, Anjana Bhuta, Ronald J. Pettis
-
Publication number: 20020022798Abstract: A wearable, self-contained drug infusion device is disclosed that is capable of achieving the precise flow rate control needed for dose-critical drugs such as insulin. In preferred embodiments of the device, at least two flow channels are utilized in conjunction with a series of valves for providing a user with selectable, constant flow rate control. The device can be made with small dimensions so that it can be worn by the user with a minimum of discomfort and inconvenience. In addition, the simple mechanical nature of the device provides the user with close control over the flow rate, which is required for safe and effective delivery of insulin and other drugs. Also, the absence of electronic components allows the device to be manufactured inexpensively. The device is provided with a first channel that is long and narrow, functioning as a flow restrictor. The first channel is preferably provided in a serpentine pattern.Type: ApplicationFiled: August 17, 2001Publication date: February 21, 2002Inventors: Robert I. Connelly, Kenneth G. Powell
-
Patent number: 6074369Abstract: A device for delivering a liquid therapeutic preparation into the body of a patient by injection into or through the skin of the patient comprises a low-profile housing having a bottom surface adapted to be brought into contact with the skin of the patient. A reservoir is disposed within the housing for containing a liquid therapeutic preparation to be administered. An injection needle is disposed generally horizontally in the housing, and is adapted to communicate with the reservoir. The injection needle has a bent injection end which is adapted to project through a needle aperture in the bottom surface of the housing. A movable needle carrier is disposed in the housing for carrying the injection needle and for causing the injection end of the needle to project through the needle aperture upon movement of the needle carrier.Type: GrantFiled: May 7, 1999Date of Patent: June 13, 2000Assignee: Becton, Dickinson and CompanyInventors: Burton H. Sage, Robert I. Connelly
-
Patent number: 5957895Abstract: A device for delivering a liquid theraputic preparation into the body of a patient by injection into or through the skin of the patient comprises a low-profile housing having a bottom surface adapted to be brought into contact with the skin of the patient. A reservoir is disposed within the housing for containing a liquid theraputic preparation to be administered. An injection needle is disposed generally horizontally in the housing, and is adapted to communicate with the reservoir. The injection needle has a bent injection end which is adapted to project through a needle aperture in the bottom surface of the housing. A movable needle carrier is disposed in the housing for carrying the injection needle and for causing the injection end of the needle to project through the needle aperture upon movement of the needle carrier.Type: GrantFiled: February 20, 1998Date of Patent: September 28, 1999Assignee: Becton Dickinson and CompanyInventors: Burton H. Sage, Robert I. Connelly